Search Results 521-530 of 16957 for rbc
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...
Development of a red blood cell transfusion requirement (at least 2 units/month for 2 months);; National Cancer Institute (NCI) CTCAE grade ≥ 3 AEs of ...
Robotic systems can help surgeons increase precision, flexibility and control for many procedures. Learn about the advantages and availability of ...
Has received transfusion of blood products (including platelets or red blood cells) or administration of colony stimulating factors (including G-CSF, GM-CSF or ...
The purpose of this research is to study immune cells called T cells and monocytes (types of blood cells that fight infection and can also cause autoimmune ...
Red cell transfusion dependency; Unfavorable Karyotype; Platelet count <100 x 109/l. Blasts in the PB and BM <20% prior to study enrollment; Availability of a ...
- Criteria must be met without erythropoietin dependency and without packed red blood cell (pRBC) transfusion within last 2 weeks. - Creatinine clearance ...
Learn about the expertise and advanced diagnostic and treatment services for people with complex or serious conditions of the heart and blood vessels.
Learn about the expertise and services at Mayo Clinic vascular centers for adults and children with conditions of the blood vessel and lymphatic systems.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.